Wealth Enhancement Trust Services’s Mesa Laboratories MLAB Stock Holding History

Wealth Enhancement Trust Services’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.99K	Buy	+20	New	+$2.01K	﹤0.01%	1004

Other funds holding MLAB

LPP

Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Wealth Enhancement Trust Services's MLAB Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in Mesa Laboratories (MLAB) in Q2 2026: 20 shares worth $1.99K. The stake represents ﹤0.01% of the portfolio and ranks #1004 among its holdings.

95 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

Wealth Enhancement Trust Services held 20 shares of Mesa Laboratories worth $1.99K as of Q2 2026.
Mesa Laboratories was a new Wealth Enhancement Trust Services position in Q2 2026.
Mesa Laboratories made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #1004 holding.
95 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.